Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Study of Solithromycin in Female Patients with Mycoplasma genitalium Infection (SOL-FEM)
jRCTs031250792Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Mar 2026
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of solithromycin in Mycoplasma genitalium infection (Mgen) (2 arms), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Bacteriological efficacy at Test-of-Cure visit. Started Mar 2026; status: recruiting.
02
Drugs
solithromycin
03
Conditions
Mycoplasma genitalium infection (Mgen)
Beyond the preview
Go deeper on jRCTs031250792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250792.